ARCHIVES

Obituaries: Karen Johnson of NCI; Merrill Egorin of UPCI

This article is from The Cancer Letter archive.

Vol. 36 No. 33 | September 17, 2010

Download PDF Visit The Full Archive

Related Articles

Phase II Elotuzumab Study Demonstrates 33 Months PFS

July 26, 2013

FDA News: Avastin Combination Approved In Recurrent Ovarian Cancer

November 14, 2014

NCI Critics Take Their Best Shots, Seek New Emphasis On Prevention At Kennedy Hearings

March 16, 1979

Hormone Therapy Can Reduce Survival In Men With Heart Problems

August 26, 2011

Sprycell Approved for CML

November 5, 2010

NCI To Pay 34 Percent Of Grants, At 155 Payline; $100 Million for Centers to Fund All Core Grants

January 29, 1988